Defiance Nasdaq Junior Biotechnology ETF is a ETF series of ETF Series Solutions (series S000064808). Net assets $7.2M as of 2021-09-30. Index fund.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Intellia Therapeutics Inc | — | $225K | 310.94% |
| Zai Lab Ltd | — | $167K | 230.47% |
| Bridgebio Pharma Inc | — | $161K | 221.48% |
| Medpace Holdings Inc | — | $155K | 214.14% |
| Beam Therapeutics Inc | — | $133K | 183.07% |
| Halozyme Therapeutics Inc | — | $132K | 182.69% |
| Allakos Inc | — | $131K | 180.39% |
| Vir Biotechnology Inc | — | $130K | 179.53% |
| Fate Therapeutics Inc | — | $129K | 178.27% |
| Twist Bioscience Corp | — | $121K | 166.77% |
| Pacific Biosciences of Califor | — | $117K | 160.74% |
| Alkermes PLC | — | $114K | 156.80% |
| Kodiak Sciences Inc | — | $113K | 156.26% |
| Arvinas Inc | — | $92K | 127.56% |
| ImmunityBio Inc | — | $87K | 120.27% |
| Report date | Net assets |
|---|---|
| 2021-09-30 | $7.2M |
| 2021-06-30 | $8.2M |
| 2021-03-31 | $8.3M |
| 2020-12-31 | $8.6M |
| 2020-09-30 | $2.6M |